Clinical Trial Update: Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE) [Phase 3]

View source ↗

Summary

Phase 3 trial PROVE investigating prophylaxis of venous thromboembolism in advanced lung cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Neoplasm
• Venous Thromboembolism

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Venous Thromboembolism, Lung Neoplasm | Phase 3 | Status: TERMINATED